Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation

REFERENCES

1. 1.↵
   1. Kloppenburg M,
   2. Kwok WY

   . Hand osteoarthritis—a heterogeneous disorder. Nat Rev Rheumatol 2011;8:22–31.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Kortekaas MC,
   2. Kwok WY,
   3. Reijnierse M,
   4. Huizinga TW,
   5. Kloppenburg M

   . In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann Rheum Dis 2013;72:930–4.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Trouw LA,
   2. Rispens T,
   3. Toes RE

   . Beyond citrullination: Other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol 2017;13:331–9.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Shi J,
   2. Knevel R,
   3. Suwannalai P,
   4. van der Linden MP,
   5. Janssen GM,
   6. van Veelen PA,
   7. et al.

   Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 2011;108:17372–7.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Derksen VF,
   2. Ajeganova S,
   3. Trouw LA,
   4. van der Helm-van Mil AH,
   5. Hafstrom I,
   6. Huizinga TW,
   7. et al.

   Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present. Ann Rheum Dis 2016;76:716–20.

   OpenUrl
6. 6.↵
   1. Hermans MP,
   2. van der Velden D,
   3. Montero Cabezas JM,
   4. Putter H,
   5. Huizinga TW,
   6. Kuiper J,
   7. et al.

   Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies. Int J Cardiol 2017;240:20–4.

   OpenUrl
7. 7.↵
   1. Verheul MK,
   2. van Erp SJ,
   3. van der Woude D,
   4. Levarht EW,
   5. Mallat MJ,
   6. Verspaget HW,
   7. et al.

   Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation. Ann Rheum Dis 2016;75:1575–6.

   OpenUrlFREE Full Text
8. 8.↵
   1. Ziegelasch M,
   2. van Delft MA,
   3. Wallin P,
   4. Skogh T,
   5. Magro-Checa C,
   6. Steup-Beekman GM,
   7. et al.

   Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined european cohorts. Arthritis Res Ther 2016;18:289.

   OpenUrl
9. 9.↵
   1. Damman W,
   2. Liu R,
   3. Kroon FPB,
   4. Reijnierse M,
   5. Huizinga TWJ,
   6. Rosendaal FR,
   7. et al.

   Do comorbidities play a role in hand osteoarthritis disease burden? Data from the Hand Osteoarthritis in Secondary Care cohort. J Rheumatol 2017;44:1659–66.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Kortekaas MC,
    2. Kwok WY,
    3. Reijnierse M,
    4. Huizinga TW,
    5. Kloppenburg M

    . Osteophytes and joint space narrowing are independently associated with pain in finger joints in hand osteoarthritis. Ann Rheum Dis 2011;70:1835–7.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Kloppenburg M,
    2. Ramonda R,
    3. Kwok WY,
    4. Bobacz K,
    5. Elewaut D,
    6. Frallonardo P,
    7. et al.

    OP0095 randomized, placebo-controlled trial to evaluate clinical efficacy and structure modifying properties of subcutaneous etanercept (ETN) in patients with erosive inflammatory hand osteoarthritis (OA) [abstract]. Ann Rheum Dis 2016;75 Suppl 2:90–1.

    OpenUrl
12. 12.↵
    1. van Delft MAM,
    2. Verheul MK,
    3. Burgers LE,
    4. Derksen VFAM,
    5. van der Helm-van Mil AHM,
    6. van der Woude D,
    7. et al.

    The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. Arthritis Res Ther 2017;19:190.

    OpenUrl
13. 13.↵
    1. Bijsterbosch J,
    2. Haugen IK,
    3. Malines C,
    4. Maheu E,
    5. Rosendaal FR,
    6. Watt I,
    7. et al.

    Reliability, sensitivity to change and feasibility of three radiographic scoring methods for hand osteoarthritis. Ann Rheum Dis 2011;70:1465–7.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Dolzani P,
    2. Assirelli E,
    3. Pulsatelli L,
    4. Addimanda O,
    5. Mancarella L,
    6. Peri G,
    7. et al.

    Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis. Clin Exp Rheumatol 2011;29:1006–9.

    OpenUrlPubMed
15. 15.↵
    1. Vannini A,
    2. Fusconi M,
    3. Dall’Aglio AC,
    4. Tovoli F,
    5. Frisoni M,
    6. Zauli D

    . A seroimmunological profile of erosive hand osteoarthritis. Acta Reumatol Port 2013;38:39–43.

    OpenUrl
16. 16.↵
    1. Punzi L,
    2. Ramonda R,
    3. Deberg M,
    4. Frallonardo P,
    5. Campana C,
    6. Musacchio E,
    7. et al.

    Coll2-1, coll2-1no2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis Cartilage 2012;20:557–61.

    OpenUrlPubMed
17. 17.↵
    1. Wang W,
    2. Jian Z,
    3. Guo J,
    4. Ning X

    . Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis. Life Sci 2014;117:19–23.

    OpenUrl
18. 18.↵
    1. Turunen S,
    2. Koivula MK,
    3. Melkko J,
    4. Alasaarela E,
    5. Lehenkari P,
    6. Risteli J

    . Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis. J Transl Med 2013;11:224.

    OpenUrlCrossRefPubMed